- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02231216
Quality of Life Study About the Role of Turbinectomy in Rhinoseptoplasty (WHOQOL-BREF)
January 16, 2019 updated by: Hospital de Clinicas de Porto Alegre
The Role of Turbinectomy in Rhinoseptoplasty: a Randomized Clinical Trial With Evaluation of Quality of Life
Research Question: Performing partial turbinectomy associated with rhinoseptoplasty is responsible for an increase in quality of life related to nasal obstruction when compared to no intervention in rhinoseptoplasty inferior turbinate?
- Population: patients eligible for functional rhinoseptoplasty and / or aesthetic
- Intervention: surgery, turbinectomy of inferior turbinates
- Comparison: the absence of intervention in inferior turbinates
- Primary endpoint: Quality of life related to nasal obstruction
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rio Grande Do Sul
-
Porto Alegre, Rio Grande Do Sul, Brazil, 90035-903
- Hospital de Clinicas de Porto Alegre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 months to 90 years (ADULT, OLDER_ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Eligible patients to rhinoseptoplasty
- Patients who agreed to participate
Exclusion Criteria:
- Presence of symptoms of nasal obstruction in the absence of septal deviation, poor support of the nasal tip or clamping of the nasal valve;
- Presence of hypertrophic and obstructive inferior turbinates;
- Presence of sinonasal tumors;
- Patients undergoing treatment of other concomitant rhinoplasty entities such as inflammatory sinus pathology, adenoid hypertrophy, septal perforation, otoplasty and blepharoplasty.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Rhinoseptoplasty and turbinectomy
Patients submitted to rhinoseptoplasty associated to Endoscopic partial turbinectomy.
|
Rhinoseptoplasty without turbinectomy procedure
After medial dislocation of the inferior turbinate, proceed partial resection of the inferior turbinate in all its inferior extension in range.
Possible bleeding is cauterized.
Other Names:
Endoscopy to medial dislocation of the inferior turbinate with instrument
|
|
ACTIVE_COMPARATOR: Rhinoseptoplasty
Patients submitted only to rhinoseptoplasty, without turbinectomy procedure.
|
Rhinoseptoplasty without turbinectomy procedure
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of life related to nasal obstruction
Time Frame: 3 months
|
Quality of life will be evaluated by the WHOQOL-BREF instrument, that comprises 26 items, which measure the following broad domains: physical health, psychological health, social relationships, and environment.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Oral antihistamine
Time Frame: 3 months
|
At 90 posoperative day patients were asked if they had used oral antihistamine in the past 30 days or not
|
3 months
|
|
Nasal sneezing
Time Frame: 3 MONTHS
|
At 90 posoperative day patients were asked if they had nasal sneezing for more than one hour a day on most days, or not.
|
3 MONTHS
|
|
Nasal Rhinorrhea
Time Frame: 3 MONTHS
|
At 90 posoperative day patients were asked if they had nasal rhinorrhea for more than one hour a day on most days, or not.
|
3 MONTHS
|
|
Nasal Pruritis
Time Frame: 3 MONTHS
|
At 90 posoperative day patients were asked if they had nasal pruritis for more than one hour a day on most days, or not.
|
3 MONTHS
|
|
Allergic Conjunctivitis
Time Frame: 3 months
|
At 90 posoperative day patients were asked if they had allergic conjunctivitis for more than one hour a day on most days, or not.
|
3 months
|
|
Topical Nasal Corticosteroids
Time Frame: 3 MONTHS
|
At 90 posoperative day patients were asked if they were using topic nasal corticosteroids or not
|
3 MONTHS
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Bianca H Moura, MD, Hospital de Clinicas de Porto Alegre
- Principal Investigator: Michelle Lavinsky, PhD, Hospital de Clinicas de Porto Alegre
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Garcia JPT, Moura BH, Rodrigues VH, Vivan MA, Azevedo SM, Dolci JEL, Migliavacca R, Lavinsky-Wolff M. Inferior Turbinate Reduction during Rhinoplasty: Is There Any Effect on Rhinitis Symptoms? Int Arch Otorhinolaryngol. 2021 Aug 5;26(1):e111-e118. doi: 10.1055/s-0041-1726046. eCollection 2022 Jan.
- de Moura BH, Migliavacca RO, Lima RK, Dolci JEL, Becker M, Feijo C, Brauwers E, Lavinsky-Wolff M. Partial inferior turbinectomy in rhinoseptoplasty has no effect in quality-of-life outcomes: A randomized clinical trial. Laryngoscope. 2018 Jan;128(1):57-63. doi: 10.1002/lary.26831. Epub 2017 Aug 16.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2014
Primary Completion (ACTUAL)
March 1, 2015
Study Completion (ACTUAL)
July 1, 2016
Study Registration Dates
First Submitted
September 2, 2014
First Submitted That Met QC Criteria
September 3, 2014
First Posted (ESTIMATE)
September 4, 2014
Study Record Updates
Last Update Posted (ACTUAL)
January 17, 2019
Last Update Submitted That Met QC Criteria
January 16, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 130516
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Deviated Nasal Septum
-
Shahida Islam Medical ComplexCompletedDeviated Nasal SeptumPakistan
-
ENTrigue Surgical, Inc.Completed
-
University of Notre DameCompletedPathological Conditions, Anatomical | Deviated Nasal SeptumUnited States
-
University of Southern CaliforniaUnknownDeviated Nasal Septum | Nasal FractureUnited States
-
Samsung Medical CenterUnknownDeviated Nasal SeptumKorea, Republic of
-
St. Petersburg State Pavlov Medical UniversityActive, not recruitingDeviated Nasal Septum | Comparison of Airway Management Techniques in Functional Endoscopic Sinus Surgery | Rhinosinusitis With Polyps | Osteoma of the Paranasal SinusesRussia
-
St. Paul's Hospital, CanadaCompleted
-
King Faisal Specialist Hospital & Research CenterCompletedRhinitis | Sinus Disease | Turbinate; Hypertrophy Mucous Membrane | Deviated Nasal Septum - Congenital | Deviated Nasal Septum AcquiredSaudi Arabia
-
Assiut UniversityNot yet recruitingDeviated Nasal Septum Effect on Maxillary Sinus Volumes and Development of Maxillary Sinusitis by CTDeviated Nasal Septum and Maxillary Sinusitis
-
Baskent UniversityUnknownSeptum Deviated | Septoplasty/SeptorhinoplastyTurkey